CME Satellite Symposium

A CME Symposium during the 2026 American Academy of Family Physicians Annual FMX in Nashville, Tennessee.

AGENDA

6:30 AM           Introduction
                        Jay Shubrook, DO (Chair)

6:40 AM           Do GLP-1 RAs Work for Patients Like Mine— Type 2 Diabetes and Cardiovascular Disease?
                         Lawrence Leiter, MD, FRCPC

7:00 AM           Oral GLP-1 RA Therapy for Patients with Type 2 Diabetes and Cardiovascular Disease: Evidence and a Practical Guide for Use
                         Silvio Inzucchi, MD

7:20 AM           Case Discussions
                         Presenter: Jay Shubrook, DO
                         Panelists: Silvio Inzucchi, MD and Lawrence Leiter, MD, FRCPC

7:40 AM         Question and Answer

EDUCATIONAL OBJECTIVES

■ Apply the 2026 ADA Standards of Care guideline recommendations to identify primary care patients with T2D who are candidates for GLP-1 RA therapy, including those with established ASCVD, CKD, or multiple cardiovascular risk factors
■ Interpret the cardiovascular outcomes trial evidence with GLP-1 RA therapy and translate key fi ndings into clinical decisions for primary care patients
with T2D
■ Initiate oral or injectable GLP-1 RA therapy in appropriate primary care patients with T2D, including patients who are injection-averse, using correct dosing, titration, and administration guidance
■ Counsel primary care patients with T2D on the benefi ts, tolerability, administration requirements, and class safety profi le of GLP-1 RA therapy to support shared decision-making and long-term adherence

Educational Grant

Voxmedia International gratefully acknowledges the educational grant from Novo Nordisk Inc.

CHAIR

Jay Shubrook, DO, FACOFP, FAAFP
Professor & Diabetologist
Department of Clinical Sciences &
Community Health
Diabetes Institute
Touro University California College of
Osteopathic Medicine
Vallejo, California

FACULTY

Silvio Inzucchi, MD
Clinical Chief of the Section of Endocrinology
Professor of Medicine
Yale University School of Medicine
New Haven, Connecticut

Lawrence A. Leiter, MD, FRCPC
Division of Endocrinology & Metabolism
St. Michael’s Hospital
Professor of Medicine & Nutritional Sciences
University of Toronto
Toronto, Canada